Product image of Optiray Ultraject (Ioversol) supplied by GNH India

Optiray Ultraject

Active Ingredient:
Ioversol
Origin:
EU

Optiray Ultraject (Ioversol)

Ioversol, the active ingredient in Optiray Ultraject, is an iodinated contrast agent presented as a sterile injectable solution for intra‑arterial and intravenous use. It provides radiodensity to enhance visualization of vascular structures and tissues during imaging procedures.\n\nGNH India supplies Optiray Ultraject as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Guerbet

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Optiray Ultraject, an iodinated contrast media, is used to improve image quality in vascular and tissue imaging.\n\nAngiography: enhances visualization of arterial and venous structures during diagnostic and interventional procedures.\nComputed Tomography (CT) imaging: increases contrast between organs and vessels for clearer cross‑sectional images.\nCardiac CT: facilitates detailed assessment of coronary arteries and cardiac anatomy.

How It Works

  • Ioversol contains iodine atoms that absorb X‑ray photons, creating high radiodensity in the bloodstream and extracellular spaces. After intravenous or intra‑arterial injection, the agent distributes rapidly, outlining vascular lumens and tissue interfaces, thereby improving the contrast resolution of radiographic, fluoroscopic, and CT images.

Side Effects

  • Adverse reactions may occur following administration of iodinated contrast agents.\n\nCommon Side Effects:\n- Warm sensation or flushing at the injection site\n- Metallic taste in the mouth\n- Nausea or mild vomiting\n- Headache or dizziness\n- Transient urticaria or mild skin rash\n- Mild increase in serum creatinine\n\nSerious or Rare Side Effects:\n- Anaphylactoid or severe allergic reaction\n- Acute renal failure, especially in patients with pre‑existing kidney disease\n- Seizures or neurologic disturbances\n- Hypotension or cardiovascular collapse\n- Pulmonary edema or respiratory distress\n- Cardiac arrhythmias or arrest

Precautions & Warnings

  • When using Optiray Ultraject, clinicians should observe several safety measures.\n\nAssess renal function: evaluate serum creatinine and eGFR before administration.\nScreen for iodine or contrast allergy: obtain detailed allergy history.\nUse lowest effective dose: tailor volume to imaging requirement.\nMonitor vital signs: observe patient during and after injection.\nAvoid in uncontrolled hyperthyroidism: iodine load may exacerbate condition.\nStore at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Avoid Interactions

  • Ioversol may interact with other medicines, requiring attention to dosing and monitoring.\n\nMajor Interactions (Avoid):\n- Metformin: risk of lactic acidosis in renal impairment; consider temporary discontinuation.\n- Loop diuretics or nephrotoxic antibiotics: may increase risk of contrast‑induced nephropathy.\n- ACE inhibitors or ARBs: can potentiate renal dysfunction when combined with contrast.\n\nModerate Interactions (Monitor Closely):\n- NSAIDs: may modestly raise renal risk; monitor kidney function.\n- Thyroid hormone preparations: excess iodine can alter thyroid hormone levels; check thyroid function if needed.\n- Beta‑blockers: may mask tachycardia signs of an allergic reaction; observe hemodynamics closely.

Frequently Asked Questions

Optiray Ultraject is an iodinated radiographic contrast medium used to enhance the visibility of blood vessels and soft tissues during angiographic procedures and computed tomography (CT) scans. It helps radiologists obtain clearer images for accurate diagnosis.

Ioversol contains iodine atoms that strongly absorb X‑ray photons. After injection, it circulates in the bloodstream and distributes into extracellular spaces, creating areas of high radiodensity that outline vascular structures and organ contours, thereby improving image contrast.

The dose of Optiray Ultraject is individualized by the prescribing physician based on the specific imaging protocol, patient size, and clinical indication. Healthcare providers calculate the appropriate volume to achieve optimal image quality while minimizing exposure.

The safety of iodinated contrast agents like Optiray Ultraject in pregnancy or lactation has not been definitively established. Use is generally avoided unless the diagnostic benefit outweighs potential risks, and clinicians should discuss options with the patient.

To order Optiray Ultraject, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and necessary import documentation.

Optiray Ultraject (Ioversol) offers a low‑osmolality formulation that is comparable to other non‑ionic agents such as Iohexol or Iopamidol. It provides similar image enhancement with a favorable safety profile, especially regarding reduced incidence of discomfort and allergic reactions.

Optiray Ultraject should be stored at room temperature, below 25 °C, in its original sealed container. Protect the vial from moisture and direct sunlight. Do not freeze; inspect for particulate matter before use.

The product is supplied as a sterile injectable solution and is administered intravenously or intra‑arterially by a qualified healthcare professional. Injection rates are controlled according to the imaging protocol to ensure optimal contrast distribution.

Serious risks include severe allergic reactions (anaphylaxis), contrast‑induced nephropathy leading to acute kidney injury, and cardiovascular events such as hypotension or arrhythmias. Prompt recognition and management of these events are essential.

Patients with a known hypersensitivity to iodinated contrast media, uncontrolled hyperthyroidism, severe renal impairment, or a history of severe contrast‑related reactions should generally avoid Optiray Ultraject unless benefits clearly outweigh risks.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ioversol

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT